Abstract A025: Direct <i>in vivo</i> CRISPR screen identifies <i>BAP1</i> and <i>FAT1</i> as potent tumor suppressors in sarcomagenesis
Jianguo Huang(Duke Medical Center), David G. Kirsch(Princess Margaret Cancer Centre), Walter J. Urba(Providence Portland Medical Center), Zhaoyu Sun(Providence Portland Medical Center), Ziqiang Zhang(Chinese PLA General Hospital), Rutulkumar Patel(Duke Medical Center), Yan Ma(Gansu Agricultural University), Omar Lopez(Duke University), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Corinne M. Linardic(Duke University), Warren Floyd(Duke Medical Center), Venkatesh Rajamanickam(Cancer Institute (WIA)), Nicholas Sibinga(Albert Einstein College of Medicine), Nerissa T. Williams(Duke Medical Center), John Welle(Providence Health & Services), Lixia Luo(Duke Medical Center), Brady Bernard(Providence Portland Medical Center), Diana M. Cardona(Duke Medical Center), Brian Piening(Providence College), Andrea R. Daniel(Inserm), Kristianne M. Oristian(Duke University), Eric S. Xu(Duke Medical Center), So Young Kim(Chungbuk National University), Xingliang Liu(Sun Yat-sen University), Yaping Wu(Shanghai Jiao Tong University), Wesley Rosales(Providence Portland Medical Center), Melissa J. Kasiewicz(Providence Portland Medical Center), William Haugh(Providence Portland Medical Center), William L. Redmond(Providence St. Vincent Medical Center)
Cited by 0
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k